Japan's Shionogi seeks approval for COVID-19 pill

Drugmaker Shionogi & Co has applied for approval to make and sell its oral COVID-19 treatment in Japan, the firm said on Friday. Known as S-217622, the drug would become the country's third antiviral pill approved for coronavirus patients, following those developed by Pfizer and Merck